XML 22 R7.htm IDEA: XBRL DOCUMENT v3.24.4
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2022
Cash Flows from Operating Activities:      
Net increase (decrease) in net assets resulting from operations $ 18,619,122 $ 26,918,340 $ (6,106,946)
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:      
Proceeds from sale and settlements of investments 112,313,260 66,642,920 123,801,226
Purchases, originations and participations (99,173,887) (76,652,712) (173,321,143)
Investment increases due to payment-in-kind interest (1,207,710) (1,525,392) (819,722)
Net amortization of premium (discount) on investments (388,667) (1,560,684) (219,513)
Amortization of debt issuance cost 347,908 370,329 368,471
Amortization of deferred financing cost 565,619 286,597
Net realized (gains) losses from investments (7,292,299) 11,533,039 (5,221,051)
Net unrealized (gains) losses on investments (5,705,864) (31,941,213) 14,463,337
Loss on extinguishment of debt 296,197
(Increase) decrease in operating assets:      
Fees receivable 1,872,700
Interest receivable (342,483) (243,539) (356,000)
Due from affiliate 318,714 (137,252) (271,962)
Receivable for investments sold 984,400 (3,940,175)
Dividends receivable 138,011 107,851 (188,119)
Paydown receivable 112,500 179,515
Other receivable (34,413) 5,567 (36,992)
Prepaid share repurchase 97,904 290,137
Deferred tax benefit (expense) (887,099)
Other assets (233,323) 359,677 159,069
Increase (decrease) in operating liabilities:      
Payable for investments purchased (4,123,059) (12,426,941) 14,964,000
Accounts payable and accrued expenses 2,503,166 1,026,707 623,753
Due to Affiliate 88,148 (280,323)
Administrator expenses payable (74,911) 6,991
Interest and fees payable 77,645 187,273 503,125
Deferred revenue (421,685) 96,083 325,602
Other liabilities (138,635) (140,251) (40,586)
Net cash provided by (used in) operating activities 16,104,773 (20,706,050) (29,298,371)
Cash Flows from Financing Activities:      
Debt issuance 76,471,498 36,441,941 57,500,000
Paydowns on debt (25,178,988) (30,521,800) (55,325,000)
Debt issuance costs paid (169,888) (2,311,036)
Deferred financing costs (627,175) (935,721)
Distributions paid to shareholders (2,645,925) (265,798)
Repurchase of common shares (2,370,959) (1,058,213) (16,964,985)
Net cash provided by (used in) financing activities 45,478,563 3,926,207 (17,366,819)
Net increase (decrease) in cash and cash equivalents 61,583,336 (16,779,843) (46,665,190)
Cash and cash equivalents, beginning of period 5,988,223 22,768,066 69,433,256
Cash and cash equivalents, end of period 67,571,559 5,988,223 22,768,066
Supplemental information:      
Interest paid during the period 5,532,959 4,647,166 4,241,510
Non-cash purchase of investments 45,900,000
Non-cash sale of investments $ 45,900,000